About Neopharm Group

Neopharm Group , through its family of companies, is engaged in the research and development, manufacturing, marketing, sales and distribution of a broad range of products in the health care field in 60 countries around the world. We embrace the promotion of innovative ideas, products and services to advance health and well-being.

Our family of companies operates in three major segments: Pharmaceutical, Medical and Consumer Healthcare.

The Pharmaceutical segment was founded in 1941 and provides a complete spectrum of integrated services for international companies seeking to enter or expand their presence in the Israeli pharma, biotech and healthcare markets. For over 70 years we have grown the value of our products, consistently increased our turnover and enhanced our market leadership in Israel. We are considered the Israeli partner-of-choice and a one-stop-shop for multinational bio-pharma companies. Our success is based upon a track record of close collaboration with the  world’s leading multinational bio-pharma companies.

In pursuit of our global patient-focused mission to develop and market novel life-transforming therapies to treat patients with unmet needs around the world, we have, during the past decade, expanded our Pharmaceutical segment by the incorporation of Orphan Technologies and the acquisition of Neovii (formerly called: Fresenius Biotech). Orphan Technologies is dedicated to developing first-in-class therapeutics and life changing therapies for patients with rare disorders. Neovii is a Swiss-based, dynamic and rapidly-growing global biopharmaceutical company with more than 30 years’ experience in developing and bringing to market novel antibody therapies that improve patients’ outcomes in transplantation medicine, oncology and immune disorders. Neovii’s products are sold in more than 50 countries around the world.

The Medical segment is dedicated to the marketing and sales of equipment, instrumentation and consumables in the areas of healthcare and life science. We offer a complete platform for our multinational partners seeking expansion in the Israeli market. Dedicated departments covering every aspect from marketing and sales through applications training and technical service are in place in each of our areas of operation, including medical devices, equipment and substances as well as scientific instruments and materials for chemical analysis, biology and diagnostics areas.

The Consumer Healthcare segment offers high-quality wellness and healthcare products to consumers in Israel and around the world via our in-house development and manufacturing capabilities and our partnering with some of the world’s leading Consumer Healthcare companies. The Consumer Healthcare segment operates in the areas of infant nutrition, specialty wet-wipes, diapers, best agers, adult incontinence products, hygiene pads, personal and skin care, dietary supplements and multivitamins and over the counter medicines.


Our annual revenues exceed $US400 million. We have offices in Israel, Europe, U.S., China and the Middle East and we employ over 900 employees worldwide.

Home | About Us | Partners | Services | Corporate Citizenship | Careers | Newsroom | Contact | Legal Notice

All Rights reserved, Promedico, Israel | Design by: VAZA | WordPress Development: The Shark Lady